Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VALID Study
2006-005951-14Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diabetic glomerulosclerosis comparing Benazepril + valsartan combination therapy, Benazepril monotherapy and Valsartan monotherapy (3 arms). Primary endpoint: Progression to end-stage renal disease. Started Mar 2007; status: completed.
02
Drugs
benazeprilvalsartan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on 2006-005951-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005951-14.